Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$619K |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$47.1K |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$46.6K |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$43.2K |
| 5 |
First Trust NASDAQ Technology Dividend Index Fund
TDIV
|
+$39.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$18.7M |
| 2 |
Amazon
AMZN
|
+$1.75M |
| 3 |
Idexx Laboratories
IDXX
|
+$944K |
| 4 |
Apple
AAPL
|
+$909K |
| 5 |
ExxonMobil
XOM
|
+$703K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.92% |
| 2 | Technology | 18.68% |
| 3 | Financials | 11.45% |
| 4 | Consumer Discretionary | 8.34% |
| 5 | Energy | 7.05% |
Similar funds
Biondo Investment Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Biondo Investment Advisors held 74 positions worth $449M, up 3.5% from $434M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Biondo Investment Advisors withdrew a net $26.2M in Q4 2022, closing 1 position and reducing 47 holdings. Its most notable exit was Abiomed Inc, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
Against the trend, Biondo Investment Advisors added an estimated $619K to Shockwave Medical, Inc. Common Stock.
- Biondo Investment Advisors added most to Shockwave Medical, Inc. Common Stock in Q4 2022, an estimated $619K increase.
- Biondo Investment Advisors's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.75M.
- Biondo Investment Advisors fully exited Abiomed Inc in Q4 2022, selling an estimated $18.7M.
- Biondo Investment Advisors's ten largest holdings make up 44% of its $449M portfolio in Q4 2022.
- Biondo Investment Advisors opened 0 new positions and closed 1 in Q4 2022.
- Biondo Investment Advisors's portfolio value rose 3.5% quarter-over-quarter to $449M.
Based on Biondo Investment Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.